usefulness of Systemic Immune Inflammation Index in predicting outcomes of patients with brain tumors above cerebellum and brain stem undergoing planned surgical removal under general anesthesia
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/02/063249
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Diagnosis of supratentorial brain tumor by MRI or CT Brain
2 Undergoing elective craniotomy under general anesthesia
Exclusion Criteria
1 Patient refusal to participate in study or refusal to follow up.
2 Patients with severe anemia (hb less than 7 g per L)
3 Neutropenia( less than 1000 million per L) or active infection( TLC more than 11000 million per L)
4 Active inflammatory, hematological, or autoimmune system disease history.
5 History of Chemotherapy or Radiotherapy or Immunomodulators in past 3 months.
6 Severe conditions involving the cardiac, hepatic or the renal system
7 Previous brain tumor surgery or treatment
8 History of drug abuse or anaphylaxis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method